Company registration number 05429602 (England and Wales)
ATLANTIC RESEARCH CHEMICALS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
PAGES FOR FILING WITH REGISTRAR
ATLANTIC RESEARCH CHEMICALS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
ATLANTIC RESEARCH CHEMICALS LIMITED
BALANCE SHEET
AS AT 28 FEBRUARY 2025
28 February 2025
- 1 -
28 February 2025
29 February 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
11,950
15,972
Current assets
Stocks
161,499
179,443
Debtors
4
47,442
42,743
Cash at bank and in hand
20,533
25,746
229,474
247,932
Creditors: amounts falling due within one year
5
(22,289)
(26,699)
Net current assets
207,185
221,233
Total assets less current liabilities
219,135
237,205
Creditors: amounts falling due after more than one year
6
(704)
(2,789)
Net assets
218,431
234,416
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
217,431
233,416
Total equity
218,431
234,416
ATLANTIC RESEARCH CHEMICALS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 28 FEBRUARY 2025
28 February 2025
- 2 -

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 14 November 2025 and are signed on its behalf by:
Mr D G Pooley
Director
Company registration number 05429602 (England and Wales)
ATLANTIC RESEARCH CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 3 -
1
Accounting policies
Company information

Atlantic Research Chemicals Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit A, Stratton Business Park, Holsworthy Road, Bude, Cornwall, EX23 9NR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost net of depreciation.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Land and buildings - leasehold
25% on NBV per annum
Plant and machinery
5% to 15% on NBV per annum
Computer equipment
20% on NBV per annum
Electric bike
10% on cost per annum

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

 

Stocks comprise raw materials aswell as completed chemical compounds.

1.6
Equity instruments

Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ATLANTIC RESEARCH CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
7
8
3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 March 2024
17,384
55,289
72,673
Disposals
-
0
(14,687)
(14,687)
At 28 February 2025
17,384
40,602
57,986
Depreciation and impairment
At 1 March 2024
16,816
39,885
56,701
Depreciation charged in the year
142
1,926
2,068
Eliminated in respect of disposals
-
0
(12,733)
(12,733)
At 28 February 2025
16,958
29,078
46,036
Carrying amount
At 28 February 2025
426
11,524
11,950
At 29 February 2024
568
15,404
15,972
ATLANTIC RESEARCH CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 5 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
26,446
22,726
Other debtors
20,996
20,017
47,442
42,743
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
2,084
2,032
Trade creditors
12,095
13,087
Taxation and social security
206
1,907
Other creditors
7,904
9,673
22,289
26,699
6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
704
2,789
2025-02-282024-03-01falsefalsefalse14 November 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityJohn ForshawDaniel Pooley054296022024-03-012025-02-28054296022025-02-28054296022024-02-2905429602core:LandBuildings2025-02-2805429602core:OtherPropertyPlantEquipment2025-02-2805429602core:LandBuildings2024-02-2905429602core:OtherPropertyPlantEquipment2024-02-2905429602core:CurrentFinancialInstrumentscore:WithinOneYear2025-02-2805429602core:CurrentFinancialInstrumentscore:WithinOneYear2024-02-2905429602core:WithinOneYear2025-02-2805429602core:WithinOneYear2024-02-2905429602core:AfterOneYear2025-02-2805429602core:AfterOneYear2024-02-2905429602core:CurrentFinancialInstruments2025-02-2805429602core:CurrentFinancialInstruments2024-02-2905429602core:ShareCapital2025-02-2805429602core:ShareCapital2024-02-2905429602core:RetainedEarningsAccumulatedLosses2025-02-2805429602core:RetainedEarningsAccumulatedLosses2024-02-2905429602bus:Director22024-03-012025-02-2805429602core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-03-012025-02-2805429602core:PlantMachinery2024-03-012025-02-2805429602core:ComputerEquipment2024-03-012025-02-2805429602core:MotorVehicles2024-03-012025-02-28054296022023-03-012024-02-2905429602core:LandBuildings2024-02-2905429602core:OtherPropertyPlantEquipment2024-02-29054296022024-02-2905429602core:LandBuildings2024-03-012025-02-2805429602core:OtherPropertyPlantEquipment2024-03-012025-02-2805429602core:Non-currentFinancialInstruments2025-02-2805429602core:Non-currentFinancialInstruments2024-02-2905429602bus:PrivateLimitedCompanyLtd2024-03-012025-02-2805429602bus:FRS1022024-03-012025-02-2805429602bus:AuditExemptWithAccountantsReport2024-03-012025-02-2805429602bus:Director12024-03-012025-02-2805429602bus:SmallCompaniesRegimeForAccounts2024-03-012025-02-2805429602bus:FullAccounts2024-03-012025-02-28xbrli:purexbrli:sharesiso4217:GBP